Moderna Says Committed to Making Omicron-adaptive Vaccine Candidate Available in Aug.

SEOUL, July 19 (Korea Bizwire) – Moderna Inc., a U.S. biotech company specializing in messenger RNA (mRNA) coronavirus vaccines, is committed to making its new bivalent vaccine candidate available next month, which reportedly demonstrates a superior antibody response against omicron variants. The company announced in June that the new bivalent coronavirus booster candidate, named mRNA-1273.214, [...]